mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0005 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |